Evaluating the Use of a Remote Telehome Monitoring Hypertension Program for Patients Receiving Virtual Care (HTMTHM)
Hypertension
About this trial
This is an interventional supportive care trial for Hypertension
Eligibility Criteria
Inclusion Criteria:
- Have a diagnosis of primary, essential HTN (SBP>140/90mmHg or >130/80mmHg for diabetes)
- Have access to a phone (can be a landline)
- Have access to cellular (4G) network at their primary residence (they do not need to physically own a cellular phone but the need to be able to confirm their residence has 4G network access in order to connect the Aetonix aTouchAway platform to the network)
- Speak English or French
Exclusion Criteria:
- Patients who have been referred or who are actively managed at a specialized HTN clinic or other Telehome monitoring program
- Women who are pregnant, breastfeeding or planning to become pregnant
- Patients who are institutionalized at a retirement home, nursing home or long-term care facility
- Patients who plan on travelling out of the country for more than 2 weeks at any point during the intervention phase of the study (first 3 months)
- Patients who are cognitively impaired or experiencing acute psychiatric illness that would alter their ability to participate
Sites / Locations
- The University of Ottawa Heart InstituteRecruiting
Arms of the Study
Arm 1
Arm 2
No Intervention
Experimental
Control
Intervention
Participants will be asked to continue their usual day to day activities and take their current medications as directed. They will be sent a link by email or through MyChart to the standard video & education session on managing hypertension. They will watch the video at home on their own time. Participants will use a home blood pressure monitor to track their blood pressure (those without a blood pressure cuff will be provided one) for the 3-month intervention period. Patients will be provided instructions of when they should seek medical attention (clinical symptoms or SBP <100 or SBP >160). They will be encouraged to track their blood pressure daily and any symptoms they may be feeling.
Participants will be asked to continue their usual day to day activities and take their current medications as directed. They will be sent a link by email or through MyChart to the educational session described above in the control group section. They will receive an Aetonix aTouchAway platform monitor, which is a disease specific home monitoring device to take home for 3 month intervention period. The device will prompt the participant to check their blood pressure on a daily basis and will send all readings to the UOHI Telehome monitoring program. The telehome monitoring nursing team will monitor the readings for each participant. For hypertensive patients who are not at target with their BP, the telehome monitoring nurse will titrate medications based on an advanced medical directive every 2 weeks. Patients will be provided instructions of when they should seek medical attention (clinical symptoms or SBP <100 or SBP >160).